covaxin

COVAXIN

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals

In what Hyderabad-based Bharat Biotech claims is the largest efficacy trial in India across 25 trial sites, the company claims its Covid-19 vaccine Covaxin is 65 per cent effective against the Delta variant. In a pre-print paper that is yet to be peer-reviewed, the company claimed that the vaccine is also 63 per cent effective …

Covaxin 65% Effective Against Delta Variant, Phase 3 Study Reveals Read More »

Aarogya Setu

Aarogya Setu rolls out new feature to update Vaccination Status

As per the press release by PIB, Aarogya Setu has rolled out a feature to update Vaccination Status on the Aarogya Setu App. Here is the step wise explanation of how to update the vaccination status. How to update Vaccination status for SELF: Those who are fully Vaccinated will get a Blue Shield on the …

Aarogya Setu rolls out new feature to update Vaccination Status Read More »

Covaxin

Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha

Under Atma Nirbhar Bharat 3.0 Mission COVID Suraksha was announced by the Government of India, to accelerate the development and production of Indigenous COVID Vaccines. This is being implemented by the Department of Biotechnology, Govt. of India at Biotechnology Industry Research Assistance Council (BIRAC), New Delhi. To augment the capacity of Indigenous production of Covaxin …

Government Supports Augmentation of Manufacturing Capacity for COVAXIN production under Mission COVID Suraksha Read More »

Covaxin

DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years

The National Regulator of the country, the Drugs Controller General of India (DCGI), after careful examination, has accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covaxin (COVID vaccine) in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd on 12.05.2021. …

DCGI approves Phase 2 and 3 clinical trial of COVAXIN in the age group of 2 to 18 Years Read More »

PM Modi interacted with Chief Ministers of all states

PM Modi interacted with Chief Ministers of all states

Interacting with the Chief Ministers of all states, Mr Modi took stock of COVID-19 situation and discussed vaccination roll out programme. He said, two vaccines Covishield and Covaxin, which are made in India, have been granted approval for emergency use. He said, both the vaccines are cost-effective.

Covaxin

India’s indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials

India’s indigenous coronavirus vaccine, Covaxin, has shown to generate robust immune response in its first phase clinical trials. A detailed immunogenicity response of the first phase trials of the vaccine has been declared by the manufacturers. Covaxin, jointly developed by Hyderabad based Bharat Biotech and ICMR has been found to be safe generating no serious …

India’s indigenous coronavirus vaccine ‘Covaxin’ shows no serious adverse effects in people in its 1st phase clinical trials Read More »